Shivering. Tremor, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Oral magnesium sachet 300 mg (manufactured by Perarin Pars Co.) single dose half an hour before surgeryRoutine treatment plus. Intervention 2: Control group: Oral p
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age of 18 to 40 years, Women candidate for elective cesarean section,
Exclusion criteria
Exclusion criteria: Temperature less than 36.5 or greater than 38 centigrade, Duration of surgery longer than 180 minutes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shivering. Timepoint: Every 15 minutes immediately after spinal anesthesia until the presence of the patient in the recovery room. Method of measurement: By using a Bedside Four-Point Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: During the presence of the patient in the recovery room. Method of measurement: By taking history and clinical observation.;Hypotension. Timepoint: Every 15 minutes immediately after spinal anesthesia until the presence of the patient in the recovery room. Method of measurement: By using sphygmometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYeganeh Sangian
Hamedan University of Medical Sciences
Outcome results
None listed